Literature DB >> 32320495

Gastrointestinal tissue-based molecular biomarkers: a practical categorisation based on the 2019 World Health Organization classification of epithelial digestive tumours.

Javier I Quezada-Marín1,2, Alfred K Lam3, Atsushi Ochiai4, Robert D Odze5, Kay M Washington6, Masashi Fukayama7, Massimo Rugge8, David S Klimstra9, Iris D Nagtegaal10, Puay-Hoon Tan11, Mark J Arends12, John R Goldblum13, Ian A Cree14, Manuel Salto-Tellez1,15.   

Abstract

Molecular biomarkers have come to constitute one of the cornerstones of oncological pathology. The method of classification not only directly affects the manner in which patients are diagnosed and treated, but also guides the development of drugs and of artificial intelligence tools. The aim of this article is to organise and update gastrointestinal molecular biomarkers in order to produce an easy-to-use guide for routine diagnostics. For this purpose, we have extracted and reorganised the molecular information on epithelial neoplasms included in the 2019 World Health Organization classification of tumours. Digestive system tumours, 5th edn.
© 2020 The Authors. Histopathology published by John Wiley & Sons Ltd.

Entities:  

Keywords:  WHO; biomarkers; gastrointestinal neoplasms; genomics; molecular pathology

Mesh:

Substances:

Year:  2020        PMID: 32320495     DOI: 10.1111/his.14120

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  10 in total

Review 1.  The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.

Authors:  Daniela Bruni; Helen K Angell; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2020-08-04       Impact factor: 60.716

2.  Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer.

Authors:  Zaoqu Liu; Taoyuan Lu; Jing Li; Libo Wang; Kaihao Xu; Qin Dang; Long Liu; Chunguang Guo; Dechao Jiao; Zhenqiang Sun; Xinwei Han
Journal:  Front Immunol       Date:  2021-07-29       Impact factor: 7.561

Review 3.  Neuroendocrine Neoplasms of the Breast: The Latest WHO Classification and Review of the Literature.

Authors:  Yukinori Ozaki; Sakiko Miura; Ryosuke Oki; Teppei Morikawa; Keita Uchino
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

Review 4.  Landscape of Immunotherapy Options for Colorectal Cancer: Current Knowledge and Future Perspectives beyond Immune Checkpoint Blockade.

Authors:  Alecsandra Gorzo; Diana Galos; Simona Ruxandra Volovat; Cristian Virgil Lungulescu; Claudia Burz; Daniel Sur
Journal:  Life (Basel)       Date:  2022-02-02

5.  Comprehensive Analysis of IGFBPs as Biomarkers in Gastric Cancer.

Authors:  Qi Liu; Jianwu Jiang; Xiefu Zhang; Meixiang Zhang; Yang Fu
Journal:  Front Oncol       Date:  2021-10-21       Impact factor: 6.244

Review 6.  Undifferentiated Sarcomatoid Carcinoma of the Pancreas: From Histology and Molecular Pathology to Precision Oncology.

Authors:  Anastasios Gkountakos; Michele Simbolo; Elena Bariani; Aldo Scarpa; Claudio Luchini
Journal:  Int J Mol Sci       Date:  2022-01-24       Impact factor: 5.923

Review 7.  Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient's Stratification.

Authors:  Octav Ginghina; Ariana Hudita; Marius Zamfir; Andrada Spanu; Mara Mardare; Irina Bondoc; Laura Buburuzan; Sergiu Emil Georgescu; Marieta Costache; Carolina Negrei; Cornelia Nitipir; Bianca Galateanu
Journal:  Front Oncol       Date:  2022-03-08       Impact factor: 6.244

Review 8.  NK Cells and Other Cytotoxic Innate Lymphocytes in Colorectal Cancer Progression and Metastasis.

Authors:  Cinzia Fionda; Gianluca Scarno; Helena Stabile; Rosa Molfetta; Chiara Di Censo; Angela Gismondi; Rossella Paolini; Silvano Sozzani; Angela Santoni; Giuseppe Sciumè
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

Review 9.  The consensus immunoscore: toward a new classification of colorectal cancer.

Authors:  Anastasia Lanzi; Franck Pagès; Christine Lagorce-Pagès; Jérôme Galon
Journal:  Oncoimmunology       Date:  2020-07-11       Impact factor: 8.110

Review 10.  The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions.

Authors:  Anastasia Lanzi; F A Sinicrope; A B Benson; Jérôme Galon
Journal:  Oncoimmunology       Date:  2020-07-20       Impact factor: 8.110

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.